Skip to main content
Frontiers in Pediatrics logoLink to Frontiers in Pediatrics
. 2025 Sep 9;13:1694368. doi: 10.3389/fped.2025.1694368

Correction: Drug review: mTOR-inhibitor therapy in fetal cardiac rhabdomyoma—a tightrope walk

Nadine Muschel 1,, Michaela Höck 2,, Elke Griesmaier 2, Samira Abdel Azim 1, Elisabeth Ralser 2, Christina Schreiner 2, Elisabeth Schermer 3, Ursula Kiechl-Kohlendorfer 2, Irene Mutz-Dehbalaie 1,, Miriam Michel 3,*,
PMCID: PMC12455045  PMID: 40994531

The following Acknowledgments statement was erroneously omitted:

“The authors thank the patient and his family for their kind cooperation, and very much regret the child's adverse outcome. The authors thank E. Michel for manuscript proofreading and T. Klenner for creating the graphic and formatting the tables.”

The original version of this article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pediatrics are provided here courtesy of Frontiers Media SA

RESOURCES